Biotech looks set for a fair 2012
This article was originally published in Scrip
Executive Summary
Biotech companies and their backers are looking at 2012 with guarded optimism. Delegates and panellists at the recent BIO Investor Forum in San Francisco believe that the recent restructuring of companies is restoring investor confidence in the sector, with an increase interest in taking discovery platform businesses public. Moreover, participants at the meeting were predicting that biotech companies have nothing to fear from the FDA or the US presidential elections.